Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Coghill

Showing results (111-120 of 230) with videos related to

Pageof 23
Sort By:
Evidence-Based Mental Health|December 10, 2016
Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwaterTobias Banaschewski, Jan Buitelaar, Celine S L Chui, et al.
Disability and Rehabilitation|May 9, 2023
Fatigue experienced by people with cerebral palsy: a systematic review of assessment tools and decision treeIain Dutia, Robert Eres, Susan M Sawyer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2020
Evaluation of causality between ADHD and Parkinson's disease: Mendelian randomization studyGloria Hoi-Yee Li, Grace Mengqin Ge, Ching-Lung Cheung, et al.
Journal of Child and Adolescent Psychopharmacology|October 15, 2024
Professor Alessandro Zuddas' Impact and Legacy: The Influential Networking and Human Connection Skills of a Passionate Scientist, Clinical Academic, and Pioneer in Child and Adolescent PsychopharmacologySara Carucci, Adriana Di Martino, Francisco Xavier Castellanos, et al.
Frontiers in Psychiatry|March 2, 2026
Quantitative susceptibility mapping of brain iron in adult ADHDMarcel Schulze, Erik Autenrieth, Behrem Aslan, et al.
CNS Drugs|February 21, 2015
The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical researchNicola C Savill, Jan K Buitelaar, Ernie Anand, et al.
European Child & Adolescent Psychiatry|December 21, 2006
Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE studyUlrich Preuss, Stephen J Ralston, Gisli Baldursson, et al.
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescentsAditya N Sharma, Celso Arango, David Coghill, et al.
CNS Drugs|July 30, 2013
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorderTobias Banaschewski, César Soutullo, Michel Lecendreux, et al.
Journal of Attention Disorders|December 15, 2020
Examining the Educational Gap for Children with ADHD and Subthreshold ADHDNardia Zendarski, Shuaijun Guo, Emma Sciberras, et al.
Pageof 23

Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
Evidence-Based Mental Health|December 10, 2016
Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwaterTobias Banaschewski, Jan Buitelaar, Celine S L Chui, et al.
Disability and Rehabilitation|May 9, 2023
Fatigue experienced by people with cerebral palsy: a systematic review of assessment tools and decision treeIain Dutia, Robert Eres, Susan M Sawyer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2020
Evaluation of causality between ADHD and Parkinson's disease: Mendelian randomization studyGloria Hoi-Yee Li, Grace Mengqin Ge, Ching-Lung Cheung, et al.
Journal of Child and Adolescent Psychopharmacology|October 15, 2024
Professor Alessandro Zuddas' Impact and Legacy: The Influential Networking and Human Connection Skills of a Passionate Scientist, Clinical Academic, and Pioneer in Child and Adolescent PsychopharmacologySara Carucci, Adriana Di Martino, Francisco Xavier Castellanos, et al.
Frontiers in Psychiatry|March 2, 2026
Quantitative susceptibility mapping of brain iron in adult ADHDMarcel Schulze, Erik Autenrieth, Behrem Aslan, et al.
CNS Drugs|February 21, 2015
The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical researchNicola C Savill, Jan K Buitelaar, Ernie Anand, et al.
European Child & Adolescent Psychiatry|December 21, 2006
Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE studyUlrich Preuss, Stephen J Ralston, Gisli Baldursson, et al.
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescentsAditya N Sharma, Celso Arango, David Coghill, et al.
CNS Drugs|July 30, 2013
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorderTobias Banaschewski, César Soutullo, Michel Lecendreux, et al.
Journal of Attention Disorders|December 15, 2020
Examining the Educational Gap for Children with ADHD and Subthreshold ADHDNardia Zendarski, Shuaijun Guo, Emma Sciberras, et al.
Pageof 23